UAB Medicine Hematology and Oncology Highlights 2021
2021 Updates in Leukemia: Ponatinib + Blinatumomab in Ph+ ALL, KRT-X19 in R/R B-ALL, Aspacytarabine in Newly Diagnosed AML
Comments 0
Login to view comments.
Click here to Login
